Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance.

Schelz, Zsuzsanna; Muddather, Hiba F; Zupkó, István

Schelz, Zsuzsanna; Muddather, Hiba F; Zupkó, István.

Afiliação

Schelz Z; Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.
Muddather HF; Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.
Zupkó I; Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.

Antibiotics (Basel) ; 12(9)2023 Sep 20.

Article em En | MEDLINE | ID: mdl-37760764

Palavras-chave

HMG-CoA reductase inhibitors; drug repositioning; efflux-mediated multidrug resistance; isoprenoid synthesis; mevalonate pathway; reversal of multidrug resistance; statins

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article